Rocket One Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 3

Employees

  • Stock Symbol
  • RKTO

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.30
  • (As of Friday Closing)

Rocket One General Information

Description

Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.

Contact Information

Formerly Known As
Hoth Therapeutics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 720 Monroe Street
  • Suite E514
  • Hoboken, NJ 07030
  • United States
+1 (866)
Primary Industry
Application Specific Semiconductors
Other Industries
Aerospace and Defense
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 720 Monroe Street
  • Suite E514
  • Hoboken, NJ 07030
  • United States
+1 (866)

Rocket One Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rocket One Stock Performance

As of 20-Nov-2026, Rocket One’s stock price is $0.30. Its current market cap is $7.39M with 24.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.30 $0.28 $0.26 - $2.45 $7.39M 24.9M 342K -$0.61

Rocket One Financials Summary

As of 30-Sep-2026, Rocket One has a trailing 12-month revenue of $35.00.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 9,890 7,525 (2,824) (5,594)
Revenue 0 0 0 0
EBITDA (11,894) (12,469) (8,188) (8,106)
Net Income (11,894) (12,469) (8,188) (8,106)
Total Assets 8,660 7,603 7,713 10,243
Total Debt 0 6 31 55
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rocket One Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rocket One‘s full profile, request access.

Request a free trial

Rocket One Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-gener
Application Specific Semiconductors
Hoboken, NJ
3 As of 2025

Mountain View, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rocket One Competitors (2)

One of Rocket One’s 2 competitors is Lily AI, a Venture Capital-Backed company based in Mountain View, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lily AI Venture Capital-Backed Mountain View, CA
Pfizer Corporation New York, NY
You’re viewing 2 of 2 competitors. Get the full list »

Rocket One Patents

Rocket One Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026043989-A1 Topical aprepitant formulation Pending 21-Aug-2024
WO-2025151396-A1 Use of aprepitant for relieving side effects associated with the administration of weight loss medications Inactive 08-Jan-2024
EP-4297868-A1 Use of aprepitant for treating alzheimer's disease Pending 23-Feb-2021
EP-4297868-A4 Use of aprepitant for treating alzheimer's disease Pending 23-Feb-2021
US-12144815-B2 Use of aprepitant for treating alzheimer's disease Active 23-Feb-2021 A61K31/5377
To view Rocket One’s complete patent history, request access »

Rocket One Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rocket One Investments & Acquisitions (3)

Rocket One’s most recent deal was a Merger/Acquisition with Tracer Drone Technologies. The deal was made on 18-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tracer Drone Technologies 18-Sep-2026 Merger/Acquisition Aerospace and Defense
Obesity Treatment Development (Hoth Therapeutics / Silo Pharma) 25-Jun-2025 Joint Venture Drug Discovery
HaloVax 23-Mar-2020 Joint Venture Biotechnology
To view Rocket One’s complete investments and acquisitions history, request access »

Rocket One ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

42.42 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Rocket One’s complete esg history, request access »

Rocket One Exits (1)

Rocket One’s most recent exit was on 23-Mar-2020 from HaloVax. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
HaloVax 23-Mar-2020 Completed
  • 2 buyers
To view Rocket One’s complete exits history, request access »

Rocket One FAQs

  • When was Rocket One founded?

    Rocket One was founded in 2017.

  • Where is Rocket One headquartered?

    Rocket One is headquartered in Hoboken, NJ.

  • What is the size of Rocket One?

    Rocket One has 3 total employees.

  • What industry is Rocket One in?

    Rocket One’s primary industry is Application Specific Semiconductors.

  • Is Rocket One a private or public company?

    Rocket One is a Public company.

  • What is Rocket One’s stock symbol?

    The ticker symbol for Rocket One is RKTO.

  • What is the current stock price of Rocket One?

    As of 20-Nov-2026 the stock price of Rocket One is $0.30.

  • What is the current market cap of Rocket One?

    The current market capitalization of Rocket One is $7.39M.

  • What is Rocket One’s current revenue?

    The trailing twelve month revenue for Rocket One is $35.00.

  • Who are Rocket One’s competitors?

    Lily AI and Pfizer are competitors of Rocket One.

  • What is Rocket One’s annual earnings per share (EPS)?

    Rocket One’s EPS for 12 months was -$0.61.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process